Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
about
S100A4 interacts with p53 in the nucleus and promotes p53 degradationA robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinomaIdentification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQSerum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.Systems biology approaches to develop innovative strategies for lung cancer therapy.S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancerOsteopontin is a prognostic biomarker in non-small cell lung cancer.Lung cancer proteomics: recent advances in biomarker discoveryS100 protein family in human cancer.Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.Progress in Top-Down Proteomics and the Analysis of Proteoforms.Proteomic biomarkers in lung cancer.Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation.Changes in protein expression in rat bronchoalveolar lavage fluid after exposure to zinc oxide nanoparticles: an iTRAQ proteomic approach.S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passagesClinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer.Prognostic impact of S100A9 overexpression in non-small cell lung cancer.The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence.Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer.
P2860
Q24294804-E9BCA1B5-EDDC-4675-9AD9-C20F8ACAECDBQ28385552-E55544E7-98B1-4ACD-9A5C-5239EB96C2FCQ28743151-1A9F05DE-BEBD-43A5-96B0-6160A31D49C1Q33514817-62F09ECF-AD14-41F3-B8FB-7012731A3A28Q33720233-6333836E-BFAF-4E5E-83F3-812D372AC7FFQ34033456-8261E594-D193-44B9-B566-CED87674F08BQ34109148-782A65FA-D427-4822-BEC2-2B11EDCEEB67Q34350615-54B4E98D-82A3-4B3C-84A9-4ADDE0A9E51CQ34361505-6476A609-333F-4D88-AF11-5888EBFD84C4Q35038432-0CBE877B-157A-4EE0-BEDD-E7B83EE828BDQ35389059-CE7F4698-5E35-4999-BA1B-95DE5726D5A3Q37650123-66CC763F-94AC-49F5-8866-30948BDFE2D8Q37697035-09598414-9DEF-4B54-9242-9BBEF063F7F1Q37730532-2C370144-88B9-4E0B-AD54-6C9E78D6226BQ38100750-370A6FDD-ADFB-4C28-BF1C-94508739E243Q38258912-60023F86-3E11-4AF9-BACD-175DE5DC4FE7Q38478863-24081757-080F-471E-9D90-8B79D25F0E2FQ38748164-CE5FEFD0-F930-4676-8F38-8116C52FE978Q39202347-1EEE9A31-1A6A-4A63-A505-B0B085BB9DE5Q41421784-3020EDC0-B6B9-4E53-81F4-E833728D4EA9Q44086437-14EAEF27-B864-4550-A5F6-8946E5821A99Q44892815-3F8C7B9D-C1A8-4ACA-8FBF-4241C8F50433Q50543875-4AEC0F7A-7E88-4C65-8D55-770EF44D98C5Q50551664-6BAADB48-DC6B-4DF8-B144-B6E958A8CD45Q51596002-7F50FDF7-C106-4314-8209-2A7BE045A5EAQ53081345-606A6074-50FB-4CB1-B815-BA136D347C16Q55495092-3CDA17BE-42DE-4F38-81D5-A570F14BE623
P2860
Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Tumor expression of S100A6 cor ...... I non-small-cell lung cancer.
@en
type
label
Tumor expression of S100A6 cor ...... I non-small-cell lung cancer.
@en
prefLabel
Tumor expression of S100A6 cor ...... I non-small-cell lung cancer.
@en
P2093
P1433
P1476
Tumor expression of S100A6 cor ...... I non-small-cell lung cancer.
@en
P2093
Hirsh Koyi
Lena Kanter
Luigi De Petris
Lukas M Orre
Rolf Lewensohn
P304
P356
10.1016/J.LUNGCAN.2008.06.003
P577
2008-07-11T00:00:00Z